Several transcription factors such as Gli2, Tcf4 and Brn-2 have been implicated in the control of MITF-opposing gene programmes, but it is not known whether their expression is sufficient to immediately compensate for an acute and complete loss of MITF in MITFhigh melanoma cell lines10, 11, 60. The gene discussed is GLI2; the disease is melanoma.